Skip to content

Prognostic Factors for Acute Diarrhea in Cervical Cancer Patients Treated with Helical Tomotherapy

Prognostic Factors for Acute Diarrhea in Cervical Cancer Patients Treated with Helical Tomotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260603006
Enrollment
288
Registered
2026-06-03
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer Radiation-induced diarrhea Cervical cancer, Radiotherapy, Helical Tomotherapy, Diarrhea, Acute Toxicity, Prognosis

Interventions

Cervical cancer patients treated with pelvic helical tomotherapy and included in the retrospective assessment of diarrhea frequency during radiotherapy.
Other
Cervical cancer patients treated with helical tomotherapy

Sponsors

Buddhachinaraj phitsanulok hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Cervical cancer patients treated with pelvic helical tomotherapy. 2. Cervical cancer patients with available diarrhea toxicity records during radiotherapy will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with prior pelvic radiotherapy. 2. Patients who underwent treatment replanning during the radiotherapy course. 3. Patients who received radiotherapy primarily for hemostatic control of active bleeding.

Design outcomes

Primary

MeasureTime frame
Maximum diarrhea frequency during radiotherapy Maximum number of diarrheal episodes per day documented in clinical toxicity records during radiotherapy

Secondary

MeasureTime frame
No secondary outcome Not applicable Not applicable

Countries

Thailand

Contacts

Public Contactsuwapim chanlaor

Buddhachinaraj Phitsanulok Hospital

suwapimc67@nu.ac.th055270300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026